Teligent Pharma, Inc. is recalling 73,776 bottles of Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL) because the product may be superpotent. Some bottles were manufactured with cracked seals or caps, which can cause the medication to become too concentrated. No injuries or incidents have been reported to date regarding this recall. This prescription medication is applied to the skin and was sold nationwide in 50 mL glass bottles.
Using a superpotent lidocaine solution can cause the body to absorb too much of the drug, leading to lidocaine toxicity. Potential symptoms of toxicity include dizziness, confusion, seizures, or irregular heart rhythms.
You have 2 options:
Distributed by McKesson Corporation dba Sky Packaging.

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL, NDC 52565-009-50โ

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL, NDC 63739-997-64
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท FDA Press Release ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.